the use of prolonged-action lithium carbonate preparations ( quilonormretard and micalite ) in 53 patients with manic-depressive psychosis and schizophrenia has shown that those drugs possess pronounced prophylactic properties .
C0085217
lithium carbonate
C0005586
manic-depressive psychosis